These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 24713206)
41. Evidence for fatty acid oxidation in human placenta, and the relationship of fatty acid oxidation enzyme activities with gestational age. Rakheja D; Bennett MJ; Foster BM; Domiati-Saad R; Rogers BB Placenta; 2002 May; 23(5):447-50. PubMed ID: 12061861 [TBL] [Abstract][Full Text] [Related]
42. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. Blank M; Krause I; Fridkin M; Keller N; Kopolovic J; Goldberg I; Tobar A; Shoenfeld Y J Clin Invest; 2002 Mar; 109(6):797-804. PubMed ID: 11901188 [TBL] [Abstract][Full Text] [Related]
43. Anti-β2 glycoprotein I antibodies and pregnancy outcome in antiphospholipid syndrome. Liu XL; Xiao J; Zhu F Acta Obstet Gynecol Scand; 2013 Feb; 92(2):234-7. PubMed ID: 23157457 [TBL] [Abstract][Full Text] [Related]
44. Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies. Donohoe S; Kingdom JC; Mackie IJ; Burrell S; Quenby S; Jauniaux E; Machin SJ Thromb Haemost; 2000 Jul; 84(1):32-8. PubMed ID: 10928466 [TBL] [Abstract][Full Text] [Related]
45. Beta 2-glycoprotein I is a good indicator of certain adverse pregnancy conditions. Ulcová-Gallová Z; Bouse V; Krizanovská K; Balvín M; Rokyta Z; Netrvalová L Int J Fertil Womens Med; 2001; 46(6):304-8. PubMed ID: 11795690 [TBL] [Abstract][Full Text] [Related]
46. Highly active antiretroviral therapy does not affect mitochondrial beta-oxidation of fatty acids: an in vitro study in fibroblasts. Butt YM; Kamrudin SA; Rakheja D Pediatr Dev Pathol; 2008; 11(1):35-8. PubMed ID: 18240871 [TBL] [Abstract][Full Text] [Related]
47. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies. Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173 [TBL] [Abstract][Full Text] [Related]
49. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941 [TBL] [Abstract][Full Text] [Related]
50. Anticardiolipin and anti-beta-2-glycoprotein I antibodies. Marai I; Tincani A; Balestrieri G; Shoenfeld Y Autoimmunity; 2005 Feb; 38(1):33-8. PubMed ID: 15804703 [TBL] [Abstract][Full Text] [Related]
51. Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome. Blank M; George J; Barak V; Tincani A; Koike T; Shoenfeld Y J Immunol; 1998 Nov; 161(10):5303-12. PubMed ID: 9820503 [TBL] [Abstract][Full Text] [Related]
52. Correlation between beta-2-glycoprotein I gene polymorphism and anti-beta-2 glycoprotein I antibodies in patients with multibacillary leprosy. Brochado MJ; Figueiredo JF; Mendes-Junior CT; Louzada-Junior P; Kim OM; Roselino AM Arch Dermatol Res; 2010 Oct; 302(8):583-91. PubMed ID: 20140737 [TBL] [Abstract][Full Text] [Related]
53. Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies. Subang R; Levine JS; Janoff AS; Davidson SM; Taraschi TF; Koike T; Minchey SR; Whiteside M; Tannenbaum M; Rauch J J Autoimmun; 2000 Aug; 15(1):21-32. PubMed ID: 10936025 [TBL] [Abstract][Full Text] [Related]
54. Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies. Martínez-Zamora MA; Tassies D; Carmona F; Espinosa G; Cervera R; Reverter JC; Balasch J J Reprod Immunol; 2010 Nov; 86(2):133-40. PubMed ID: 20594598 [TBL] [Abstract][Full Text] [Related]
55. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations. Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986 [TBL] [Abstract][Full Text] [Related]
56. Oral administration of Domain-I of beta-2glycoprotein-I induces immunological tolerance in experimental murine antiphospholipid syndrome. Shemer A; Willis R; Gonzalez EB; Romay-Penabad Z; Shovman O; Shoenfeld Y; Blank M; Amital H J Autoimmun; 2019 May; 99():98-103. PubMed ID: 30797663 [TBL] [Abstract][Full Text] [Related]
58. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome. Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162 [TBL] [Abstract][Full Text] [Related]
59. The Role of TLR4 on B Cell Activation and Anti- Cheng S; Wang H; Zhou H J Immunol Res; 2016; 2016():1719720. PubMed ID: 27868072 [TBL] [Abstract][Full Text] [Related]
60. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome. von Scheven E; Glidden DV; Elder ME Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]